Precigen Inc Sustainability Reports
Precigen Inc. is a clinical-stage biopharmaceutical company focused on developing the next generation of gene and cell therapies. The company uses precision technology to target urgent diseases in immuno-oncology, autoimmune disorders, and infectious diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300XCWNQU35K64G19
FIGI: BBG001SSB3T5
3 reports from 2020 to 2023
